Latest revenue
$16.7M
as of 2026-03-31
Latest net income
$-8.4M
as of 2026-03-31
Net margin
-50.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $302.8M
- Enterprise value
- $302.8M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $17.94
- 52-wk low
- $10.92
- Beta
- —
- Shares out
- 20.7M
5-year trend
What this company does
Item 1. Business Overview We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Our ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges…
AI summary unavailable — showing raw filing excerpt
Generated from SI's filing dated 2026-03-10
Key risks
Item 1A. Risk Factors Our business involves a high degree of risk. The risks and uncertainties described below are not the only ones we face. If any of the following risks and uncertainties develop into actual events or circumstances, they could have a material adverse effect on our business, financial condition and results of operations. In that event, the market price of our common stock could decline, and you could lose all your investments. You should carefully read the following risk factors, together with our audited financial statements and the related notes and all other information included in this Annual Report and our other filings with the SEC. Risks Related to Our Financial…
AI summary unavailable — showing raw filing excerpt
Generated from SI's filing dated 2026-03-10
Profitability
Gross margin
76.5%
0.6%Operating margin
-55.6%
19.9%Net margin
-85.3%
72.7%Return on equity
-28.7%
200.4%Return on assets
-23.8%
34.5%Leverage
Debt / equity
0.21×
111.6%Long-term debt / equity
0.11×
139.5%Debt / assets
17.2%
92.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $16.7M | +64.9% | $-8.4M | -79.7% | -50.1% |
Q4 2025 2025-12-31 | $14.4M | — | $-7.8M | — | -53.9% |
Q3 2025 2025-09-30 | $11.8M | +57.7% | $-8.7M | -115.3% | -74.3% |
Q2 2025 2025-06-30 | $11.0M | +33.3% | $-19.2M | -360.1% | -174.3% |
Q1 2025 2025-03-31 | $10.1M | — | $-4.7M | — | -46.0% |
Q3 2024 2024-09-30 | $7.5M | — | $-4.1M | — | -54.4% |
Q2 2024 2024-06-30 | $8.3M | — | $-4.2M | — | -50.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on SI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$12.0M
Insider selling
$0
Net activity
+$12.0M
Distinct insiders
8
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns SI
Institutional value
$31.5M
Total shares held
2.2M
Distinct holders
31
-18 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 556.1K | $8.1M | +244.7K (+78.6%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 413.5K | $6.0M | — | New |
| 3 | TimesSquare Capital Management, LLC | 322.8K | $4.7M | +32.9K (+11.4%) | Added |
| 4 | Roubaix Capital, LLC | 257.1K | $3.7M | +98.3K (+61.9%) | Added |
| 5 | Walleye Capital LLC | 170.4K | $2.5M | +76.9K (+82.3%) | Added |
| 6 | JPMORGAN CHASE & CO | 130.7K | $1.9M | +128.8K (+6722.1%) | Added |
| 7 | CM Management, LLC | 100.0K | $1.5M | +75.0K (+300.0%) | Added |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 61.0K | $886.3K | — | New |
| 9 | VANGUARD FIDUCIARY TRUST CO | 37.6K | $546.6K | — | New |
| 10 | KCM Capital Inc | 35.0K | $508.6K | — | New |
| 11 | Bank of New York Mellon Corp | 17.4K | $252.3K | — | New |
| 12 | Blue Trust, Inc. | 15.7K | $228.4K | — | New |
| 13 | Nuveen, LLC | 12.2K | $176.9K | — | New |
| 14 | DEUTSCHE BANK AG\ | 9.3K | $135.6K | +5.2K (+125.8%) | Added |
| 15 | UBS Group AG | 5.0K | $73.2K | +3.5K (+221.7%) | Added |
| 16 | RHUMBLINE ADVISERS | 4.7K | $68.9K | +1.6K (+51.5%) | Added |
| 17 | WELLS FARGO & COMPANY/MN | 3.8K | $55.7K | -1.4K (-27.0%) | Trimmed |
| 18 | China Universal Asset Management Co., Ltd. | 3.6K | $52.3K | — | New |
| 19 | Vanguard Global Advisers, LLC | 2.8K | $40.2K | — | New |
| 20 | Police & Firemen's Retirement System of New Jersey | 2.5K | $36.9K | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once SI's latest filing finishes processing.